Arcutis Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $71,360 | $44,755 | $30,858 | $49,569 |
Gross Profit | 64,455 | 39,252 | 27,394 | 46,313 |
EBITDA | -4,456 | -33,452 | -44,497 | -31,264 |
EBIT | -4,914 | -34,884 | -44,848 | -31,307 |
Net Income | -10,788 | -41,537 | -52,332 | -35,382 |
Net Change In Cash | 71,360 | 44,755 | 30,858 | 49,569 |
Free Cash Flow | -5,748 | -34,831 | -45,119 | -31,603 |
Cash | 71,335 | 134,851 | 84,887 | 190,714 |
Basic Shares | 120,957 | 124,302 | 123,480 | 111,048 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $196,542 | $59,606 | $3,686 | $0 |
Gross Profit | 177,414 | 54,619 | 2,932 | -763 |
EBITDA | -109,625 | -227,434 | -294,553 | -206,075 |
EBIT | -112,224 | -229,315 | -295,806 | -206,529 |
Net Income | -140,039 | -262,140 | -321,289 | -205,902 |
Net Change In Cash | 196,542 | 59,606 | 3,686 | 0 |
Cost of Revenue | 31,367 | |||
Free Cash Flow | -112,301 | -247,485 | -280,998 | -175,622 |
Cash | 71,335 | 88,398 | 53,641 | 96,449 |
Basic Shares | 120,957 | 69,305 | 55,032 | 49,405 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.09 |
2024-09-30 | -$0.33 |
2024-06-30 | -$0.42 |
2024-03-31 | -$0.32 |
